Intervertebral disc degeneration (IVDD) constitutes a major source of chronic low back pain and functional limitation worldwide, substantially impairing physical activity, sports performance, and ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Microsoft spent $88.7B on capex in fiscal 2025 for AI infrastructure. This exceeded the projected $80B. Analysts set a $631 price target for Microsoft stock. This implies 30% upside from current ...

Type 1 diabetes (T1D) is characterized by the autoimmune destruction of insulin-producing β-cells in the pancreas. Regulatory T cells (Tregs) are essential for maintaining immune tolerance, but they ...

From the advent of new innovations to shifting care models, healthcare leaders reflect on what words and trends will define the spine surgery field in 2026. The 23 leaders featured in this article are ...

I am a Backend Developer and Software Engineer with a solid background in Artificial Intelligence in academic and professional fields, looking forwa ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

NervGen Pharma Corp., a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic disorders, today ...

Nes-Ziona, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. ( Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive ...

Microsoft has announced the general availability of Azure Functions Durable Task Scheduler including the Dedicated SKU to support long-running, event-driven workflows, while the Consumption SKU enters ...

BOSTON--(BUSINESS WIRE)--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of longer-term results from the global Phase 3 ...